$AURA

$6.18 -$0.12 (1.9%) Close

$AURA Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Company Executives

$AURA Management Team

Dr. Elisabet De Los Pinos

President

Chief Executive Officer

Director

Age 52

Compensation $3.604M USD

Sex Female

Mr. Anthony Gibney

Chief Financial and Business Officer

Age 54

Compensation -

Sex Male

Ms. Amy Elazzouzi

Senior Vice President - Finance

Age 51

Compensation -

Sex Female

Mr. Conor Kilroy

General Counsel

Company Secretary

Age 42

Compensation $2.022M USD

Sex Male

Dr. Mark Plavsic

Chief Technology Officer

Age 63

Compensation -

Sex Male

Mr. David Johnson

Independent Chairman of the Board

Age 60

Compensation $231.4K USD

Sex Male

Dr. J. Jill Hopkins

Chief Medical Officer and President of Research & Development

Age 59

Compensation $1.226M USD

Sex Female

Name / Title	Age	Compensation	Sex
Dr. Elisabet De Los Pinos President Chief Executive Officer Director	52	$3.604M USD	Female
Mr. Anthony Gibney Chief Financial and Business Officer	54	-	Male
Ms. Amy Elazzouzi Senior Vice President - Finance	51	-	Female
Mr. Conor Kilroy General Counsel Company Secretary	42	$2.022M USD	Male
Dr. Mark Plavsic Chief Technology Officer	63	-	Male
Mr. David Johnson Independent Chairman of the Board	60	$231.4K USD	Male
Dr. J. Jill Hopkins Chief Medical Officer and President of Research & Development	59	$1.226M USD	Female

Board of Directors

From the proxy statement filed Apr 20, 2026

Directors

serving now

Independent

6 of 7

stated in the proxy

Average tenure

6.7 years

from year joined

CEO also chairs the board

David Johnson

Director	Age	On board	Independent	Committees	Other public boards	2025 pay
Elisabet de los Pinos CEO	53	2009 17 years	Not independent	None stated	None stated	Paid as CEO
Giovanni Mariggi	41	2019 7 years	Independent	Audit Committee Compensation Committee · Chair	Fore Biotherapeutics US Inc., Vaderis Therapeutics AG, Curevo Inc., Vicebio Ltd.	Not stated
Antony Mattessich	59	2021 5 years	Independent	Audit Committee Nominating and Corporate Governance Committee · Chair	None stated	$214,891
Sapna Srivastava	55	2021 5 years	Independent	Audit Committee · Chair	Nuvalent, Inc., Alumis, Inc.	Not stated
Teresa Marie Bitetti	63	2025 1 year	Independent	Compensation Committee	Osmol Therapeutics, Inc.	$283,562
David Johnson Board chair	61	2021 5 years	Independent	Nominating and Corporate Governance Committee	Zentalis Pharmaceuticals, Inc.	$235,331
Karan Takhar Leaving at the meeting	Not stated	Not stated	Independent	Compensation Committee Nominating and Corporate Governance Committee	None stated	Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 20, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Comments

Company Executives

$AURA Management Team

Dr. Elisabet De Los Pinos

Mr. Anthony Gibney

Ms. Amy Elazzouzi

Mr. Conor Kilroy

Dr. Mark Plavsic

Mr. David Johnson

Dr. J. Jill Hopkins

Board of Directors

Related-party transactions

No related-party transactions disclosed